0082. Early circulating lipid and cytokine profiles prognosticate in a rat model of faecal peritonitis by unknown
POSTER PRESENTATION Open Access
0082. Early circulating lipid and cytokine profiles
prognosticate in a rat model of faecal peritonitis
W Khaliq*, M Singer
From ESICM LIVES 2014
Barcelona, Spain. 27 September - 1 October 2014
Introduction
In stress states, catecholamines induce lipolysis and
insulin resistance with hyperglycaemia. Lipid profiles dif-
fer between surviving and non-surviving septic patients
[1,2] but, hitherto, little attention has been paid to this
finding and its significance remains unknown. We used a
previously characterized 72h fluid-resuscitated rat model
of faecal peritonitis where prognostication can be made
with high sensitivity and specificity as early as 6h from
heart rate or stroke volume [3].
Objectives
To determine the relationship between early changes in
plasma cytokine and metabolic profiles, and their prog-
nostic significance.
Methods
Under general anaesthesia male Wistar rats (325±15g)
underwent tunneled insertion of carotid arterial and
jugular venous lines, followed by i.p. injection of 4µl/g
faecal slurry. They were then woken and attached to a
swivel-tether system allowing free movement in their
cage with, from 2h, fluid resuscitation (1:1 mix of 5%
dextrose:Hartmann’s) at 10ml/kg/h. An echocardiogra-
phy-measured HR cut-off of 460 bpm was used to clas-
sify animals into predicted survivors or non-survivors.
At 6h, animals were sacrificed for blood and tissue sam-
pling. We here report plasma levels of IL-6, IL-10, and a
metabolic profile using blood gas analysis, ELISA and
enzymatic colorometric testing.
Results
At 6h the animals manifested only mild clinical features
of illness, however significant differences were seen in
IL-6 and all lipid measurements between predicted sur-
vivors and non-survivors. Glucose, lactate and IL-10
levels did not differ. Table 1
Conclusions
In this long-term rat model of faecal peritonitis, predicted
non-survivors had a significantly different IL-6 and lipid
profile as early as 6 hours after sepsis. IL-6 impacts on
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Table 1
Predicted survival (n=6) Predicted non-survival (n=6)
IL-6 (ng/mL) 0.94 ± 0.23 3.70 ± 0.83*
IL-10 (ng/mL) 0.33 ± 0.05 0.30 ± 0.12
Glucose (mmol/L) 6.8 ± 0.7 6.9 ± 0.6
Lactate (mmol/L) 1.9 ± 0.5 1.6 ± 0.5
HDL cholesterol (mmol/L) 0.88 ± 0.04 0.73 ± 0.07*
LDL/VLDL cholesterol (mmol/L) 0.50 ± 0.03 0.39 ± 0.03*
Triglyceride (mmol/L) 1.12 ± 0.04 0.75 ± 0.08*
[Data shown as median ± SE; * p<0.05]
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lipid metabolism [4] but the relationship in sepsis has not,
to our knowledge, been previously described. The impact
of early hypolipidaemia on outcome warrants further
investigation.
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